# Tiotropium In Exercise

> **NCT00525512** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 519 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Exercise

## Interventions

- **DRUG:** tiotropium 18 mcg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00525512
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-06
- **Final completion:** —
- **Target enrollment:** 519 (ACTUAL)
- **Last updated:** 2013-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525512, "Tiotropium In Exercise". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00525512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*